Selected research
Market Analysis & Forecast
Global Azithromycin Drug Market Analysis and Forecast 2026-2032
Market perspective
The global Azithromycin Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Azithromycin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Azithromycin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Azithromycin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Azithromycin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Azithromycin Drug include Teva, Sandoz, Mylan, Pfizer, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Zydus Pharmaceuticals, Wockhardt and PLIVA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Azithromycin Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Azithromycin Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Azithromycin Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Azithromycin Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Azithromycin Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Azithromycin Drug sales, projected growth trends, production technology, application and end-user industry.
Azithromycin Drug Segment by Company
Teva
Sandoz
Mylan
Pfizer
Hainan Poly Pharm
Hainan Hailing Chemipharma Corporation
Zydus Pharmaceuticals
Wockhardt
PLIVA
Lupin
Gland Pharma Limited
CSPC Ouyi Pharmaceutical
CSPC
Aurobindo Pharma
Akorn
Azithromycin Drug Segment by Type
Oral
Injection
Azithromycin Drug Segment by Application
Hospital
Drug Store
Azithromycin Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azithromycin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Azithromycin Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Azithromycin Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Azithromycin Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Sandoz
- Mylan
- Pfizer
- Hainan Poly Pharm
- Hainan Hailing Chemipharma Corporation
- Zydus Pharmaceuticals
- Wockhardt
- PLIVA
- Lupin
- Gland Pharma Limited
- CSPC Ouyi Pharmaceutical
- CSPC
- Aurobindo Pharma
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Azithromycin Drug Market by Type
- 1.2.1 Global Azithromycin Drug Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Oral
- 1.2.3 Injection
- 1.3 Azithromycin Drug Market by Application
- 1.3.1 Global Azithromycin Drug Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drug Store
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Azithromycin Drug Market Dynamics
- 2.1 Azithromycin Drug Industry Trends
- 2.2 Azithromycin Drug Industry Drivers
- 2.3 Azithromycin Drug Industry Opportunities and Challenges
- 2.4 Azithromycin Drug Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Azithromycin Drug Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Azithromycin Drug Revenue by Region
- 3.2.1 Global Azithromycin Drug Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Azithromycin Drug Revenue by Region (2021-2026)
- 3.2.3 Global Azithromycin Drug Revenue by Region (2027-2032)
- 3.2.4 Global Azithromycin Drug Revenue Market Share by Region (2021-2032)
- 3.3 Global Azithromycin Drug Sales Estimates and Forecasts 2021-2032
- 3.4 Global Azithromycin Drug Sales by Region
- 3.4.1 Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Azithromycin Drug Sales by Region (2021-2026)
- 3.4.3 Global Azithromycin Drug Sales by Region (2027-2032)
- 3.4.4 Global Azithromycin Drug Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Azithromycin Drug Revenue by Manufacturers
- 4.1.1 Global Azithromycin Drug Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Azithromycin Drug Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Azithromycin Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Azithromycin Drug Sales by Manufacturers
- 4.2.1 Global Azithromycin Drug Sales by Manufacturers (2021-2026)
- 4.2.2 Global Azithromycin Drug Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Azithromycin Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Azithromycin Drug Sales Price by Manufacturers (2021-2026)
- 4.4 Global Azithromycin Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Azithromycin Drug Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Azithromycin Drug Manufacturers, Product Type & Application
- 4.7 Global Azithromycin Drug Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Azithromycin Drug Market CR5 and HHI
- 4.8.2 2025 Azithromycin Drug Tier 1, Tier 2, and Tier 3
5 Azithromycin Drug Market by Type
- 5.1 Global Azithromycin Drug Revenue by Type
- 5.1.1 Global Azithromycin Drug Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Azithromycin Drug Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Azithromycin Drug Revenue Market Share by Type (2021-2032)
- 5.2 Global Azithromycin Drug Sales by Type
- 5.2.1 Global Azithromycin Drug Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Azithromycin Drug Sales by Type (2021-2032) & (W Units)
- 5.2.3 Global Azithromycin Drug Sales Market Share by Type (2021-2032)
- 5.3 Global Azithromycin Drug Price by Type
6 Azithromycin Drug Market by Application
- 6.1 Global Azithromycin Drug Revenue by Application
- 6.1.1 Global Azithromycin Drug Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Azithromycin Drug Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Azithromycin Drug Revenue Market Share by Application (2021-2032)
- 6.2 Global Azithromycin Drug Sales by Application
- 6.2.1 Global Azithromycin Drug Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Azithromycin Drug Sales by Application (2021-2032) & (W Units)
- 6.2.3 Global Azithromycin Drug Sales Market Share by Application (2021-2032)
- 6.3 Global Azithromycin Drug Price by Application
7 Company Profiles
- 7.1 Teva
- 7.1.1 Teva Company Information
- 7.1.2 Teva Business Overview
- 7.1.3 Teva Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Azithromycin Drug Product Portfolio
- 7.1.5 Teva Recent Developments
- 7.2 Sandoz
- 7.2.1 Sandoz Company Information
- 7.2.2 Sandoz Business Overview
- 7.2.3 Sandoz Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sandoz Azithromycin Drug Product Portfolio
- 7.2.5 Sandoz Recent Developments
- 7.3 Mylan
- 7.3.1 Mylan Company Information
- 7.3.2 Mylan Business Overview
- 7.3.3 Mylan Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Mylan Azithromycin Drug Product Portfolio
- 7.3.5 Mylan Recent Developments
- 7.4 Pfizer
- 7.4.1 Pfizer Company Information
- 7.4.2 Pfizer Business Overview
- 7.4.3 Pfizer Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Pfizer Azithromycin Drug Product Portfolio
- 7.4.5 Pfizer Recent Developments
- 7.5 Hainan Poly Pharm
- 7.5.1 Hainan Poly Pharm Company Information
- 7.5.2 Hainan Poly Pharm Business Overview
- 7.5.3 Hainan Poly Pharm Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Hainan Poly Pharm Azithromycin Drug Product Portfolio
- 7.5.5 Hainan Poly Pharm Recent Developments
- 7.6 Hainan Hailing Chemipharma Corporation
- 7.6.1 Hainan Hailing Chemipharma Corporation Company Information
- 7.6.2 Hainan Hailing Chemipharma Corporation Business Overview
- 7.6.3 Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio
- 7.6.5 Hainan Hailing Chemipharma Corporation Recent Developments
- 7.7 Zydus Pharmaceuticals
- 7.7.1 Zydus Pharmaceuticals Company Information
- 7.7.2 Zydus Pharmaceuticals Business Overview
- 7.7.3 Zydus Pharmaceuticals Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Zydus Pharmaceuticals Azithromycin Drug Product Portfolio
- 7.7.5 Zydus Pharmaceuticals Recent Developments
- 7.8 Wockhardt
- 7.8.1 Wockhardt Company Information
- 7.8.2 Wockhardt Business Overview
- 7.8.3 Wockhardt Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Wockhardt Azithromycin Drug Product Portfolio
- 7.8.5 Wockhardt Recent Developments
- 7.9 PLIVA
- 7.9.1 PLIVA Company Information
- 7.9.2 PLIVA Business Overview
- 7.9.3 PLIVA Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 PLIVA Azithromycin Drug Product Portfolio
- 7.9.5 PLIVA Recent Developments
- 7.10 Lupin
- 7.10.1 Lupin Company Information
- 7.10.2 Lupin Business Overview
- 7.10.3 Lupin Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Lupin Azithromycin Drug Product Portfolio
- 7.10.5 Lupin Recent Developments
- 7.11 Gland Pharma Limited
- 7.11.1 Gland Pharma Limited Company Information
- 7.11.2 Gland Pharma Limited Business Overview
- 7.11.3 Gland Pharma Limited Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Gland Pharma Limited Azithromycin Drug Product Portfolio
- 7.11.5 Gland Pharma Limited Recent Developments
- 7.12 CSPC Ouyi Pharmaceutical
- 7.12.1 CSPC Ouyi Pharmaceutical Company Information
- 7.12.2 CSPC Ouyi Pharmaceutical Business Overview
- 7.12.3 CSPC Ouyi Pharmaceutical Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio
- 7.12.5 CSPC Ouyi Pharmaceutical Recent Developments
- 7.13 CSPC
- 7.13.1 CSPC Company Information
- 7.13.2 CSPC Business Overview
- 7.13.3 CSPC Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 CSPC Azithromycin Drug Product Portfolio
- 7.13.5 CSPC Recent Developments
- 7.14 Aurobindo Pharma
- 7.14.1 Aurobindo Pharma Company Information
- 7.14.2 Aurobindo Pharma Business Overview
- 7.14.3 Aurobindo Pharma Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Aurobindo Pharma Azithromycin Drug Product Portfolio
- 7.14.5 Aurobindo Pharma Recent Developments
- 7.15 Akorn
- 7.15.1 Akorn Company Information
- 7.15.2 Akorn Business Overview
- 7.15.3 Akorn Azithromycin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Akorn Azithromycin Drug Product Portfolio
- 7.15.5 Akorn Recent Developments
8 North America
- 8.1 North America Azithromycin Drug Market Size by Type
- 8.1.1 North America Azithromycin Drug Revenue by Type (2021-2032)
- 8.1.2 North America Azithromycin Drug Sales by Type (2021-2032)
- 8.1.3 North America Azithromycin Drug Price by Type (2021-2032)
- 8.2 North America Azithromycin Drug Market Size by Application
- 8.2.1 North America Azithromycin Drug Revenue by Application (2021-2032)
- 8.2.2 North America Azithromycin Drug Sales by Application (2021-2032)
- 8.2.3 North America Azithromycin Drug Price by Application (2021-2032)
- 8.3 North America Azithromycin Drug Market Size by Country
- 8.3.1 North America Azithromycin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Azithromycin Drug Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Azithromycin Drug Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Azithromycin Drug Market Size by Type
- 9.1.1 Europe Azithromycin Drug Revenue by Type (2021-2032)
- 9.1.2 Europe Azithromycin Drug Sales by Type (2021-2032)
- 9.1.3 Europe Azithromycin Drug Price by Type (2021-2032)
- 9.2 Europe Azithromycin Drug Market Size by Application
- 9.2.1 Europe Azithromycin Drug Revenue by Application (2021-2032)
- 9.2.2 Europe Azithromycin Drug Sales by Application (2021-2032)
- 9.2.3 Europe Azithromycin Drug Price by Application (2021-2032)
- 9.3 Europe Azithromycin Drug Market Size by Country
- 9.3.1 Europe Azithromycin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Azithromycin Drug Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Azithromycin Drug Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Azithromycin Drug Market Size by Type
- 10.1.1 China Azithromycin Drug Revenue by Type (2021-2032)
- 10.1.2 China Azithromycin Drug Sales by Type (2021-2032)
- 10.1.3 China Azithromycin Drug Price by Type (2021-2032)
- 10.2 China Azithromycin Drug Market Size by Application
- 10.2.1 China Azithromycin Drug Revenue by Application (2021-2032)
- 10.2.2 China Azithromycin Drug Sales by Application (2021-2032)
- 10.2.3 China Azithromycin Drug Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Azithromycin Drug Market Size by Type
- 11.1.1 Asia Azithromycin Drug Revenue by Type (2021-2032)
- 11.1.2 Asia Azithromycin Drug Sales by Type (2021-2032)
- 11.1.3 Asia Azithromycin Drug Price by Type (2021-2032)
- 11.2 Asia Azithromycin Drug Market Size by Application
- 11.2.1 Asia Azithromycin Drug Revenue by Application (2021-2032)
- 11.2.2 Asia Azithromycin Drug Sales by Application (2021-2032)
- 11.2.3 Asia Azithromycin Drug Price by Application (2021-2032)
- 11.3 Asia Azithromycin Drug Market Size by Country
- 11.3.1 Asia Azithromycin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Azithromycin Drug Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Azithromycin Drug Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Azithromycin Drug Market Size by Type
- 12.1.1 SAMEA Azithromycin Drug Revenue by Type (2021-2032)
- 12.1.2 SAMEA Azithromycin Drug Sales by Type (2021-2032)
- 12.1.3 SAMEA Azithromycin Drug Price by Type (2021-2032)
- 12.2 SAMEA Azithromycin Drug Market Size by Application
- 12.2.1 SAMEA Azithromycin Drug Revenue by Application (2021-2032)
- 12.2.2 SAMEA Azithromycin Drug Sales by Application (2021-2032)
- 12.2.3 SAMEA Azithromycin Drug Price by Application (2021-2032)
- 12.3 SAMEA Azithromycin Drug Market Size by Country
- 12.3.1 SAMEA Azithromycin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Azithromycin Drug Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Azithromycin Drug Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Azithromycin Drug Value Chain Analysis
- 13.1.1 Azithromycin Drug Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Azithromycin Drug Production Mode & Process
- 13.2 Azithromycin Drug Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Azithromycin Drug Distributors
- 13.2.3 Azithromycin Drug Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst